Detailed Coverage

Sanofi Consumer Healthcare India Reports Profitable Q2 2026

Sanofi Consumer Healthcare India's Q2 2026 revenue reached ₹235.7 crore, with a profit of ₹68.8 crore.
Reader Takeaway: Profitable recovery driven by brand relaunches; watch for growth sustainability.

What just happened

Sanofi Consumer Healthcare India reported a profit of ₹68.8 crore for the quarter ending June 30, 2026. Revenue from operations stood at ₹235.7 crore. The company also reported half-year revenue of ₹464.9 crore and half-year operating cash inflow of ₹109.6 crore.

Why this matters

These results signal a recovery and profitable growth for the company following a precautionary recall of key brands like Combiflam and Allegra in 2024. The successful relaunch of these brands is crucial for stabilizing revenue and demonstrating the company's independent operational strength.

The backstory

In 2024, Sanofi Consumer Healthcare India experienced disruptions due to a precautionary recall of several popular brands. This impacted comparability with previous financial periods. The company has since been working on relaunching these brands.

What changes now

The successful relaunch of brands such as Combiflam, Allegra, and Depura is now reflected in the Q2 2026 financial performance. The company is focused on investing in go-to-market capabilities to drive future profitability.

Risks to watch

Management notes that results are not fully comparable with the corresponding periods of the previous year due to the product recall in 2024. Investors should be mindful of this when analyzing year-on-year growth figures.

Peer comparison

No direct peer comparison data is available in the filing. However, the recovery of key brands suggests a competitive market presence.

Context metrics (time-bound)

• Q2 2026 Revenue: ₹235.7 crore
• Q2 2026 Profit: ₹68.8 crore
• Q2 2026 EPS: ₹29.87
• H1 2026 Cash Inflow (Ops): ₹109.6 crore
• As of June 30, 2026: Total Assets ₹706.4 crore, Total Liabilities ₹358.5 crore.

What to track next

Investors should monitor the company's ability to sustain this growth momentum in upcoming quarters, especially as the base becomes more comparable year-on-year, and how it manages brand investments.